On this page:Overview Publications Researchers Institutions Open access

PICO Portalanswers from OpenAlex

AgeneBio (United States)

InstitutionResearch output, impact & collaborations

AgeneBio (United States) is a institution indexed in PICO Portal from OpenAlex.

What is known about AgeneBio (United States)?

PICO Portalrecord summary

AgeneBio (United States) is a research organisation in Baltimore, United States. OpenAlex records 13 works and 507 citations for it. 1 researchers list it as their most recent affiliation.

How many works does AgeneBio (United States) have?

PICO Portalindexed works

AgeneBio (United States) has 13 works in the PICO Portal index. The count is the OpenAlex total, not the number of papers listed on this page.

See the works listed for AgeneBio (United States) →

How many citations does AgeneBio (United States) have?

PICO Portalcitation count

AgeneBio (United States) has 507 citations in the OpenAlex counts PICO Portal stores.

See the listed works for AgeneBio (United States) →

How many researchers are at AgeneBio (United States)?

PICO Portalresearcher count

AgeneBio (United States) has 1 researchers in the PICO Portal index.

See the researchers listed on this page →

What is the average h-index at AgeneBio (United States)?

PICO Portalavg h-index

AgeneBio (United States) has an average h-index of 74 in OpenAlex.

Open the OpenAlex record →

What is the ROR of AgeneBio (United States)?

PICO Portalror

The ROR for AgeneBio (United States) is on the source record.

Open the ROR →

What is the OpenAlex record for AgeneBio (United States)?

PICO Portalopenalex

The OpenAlex for AgeneBio (United States) is on the source record.

Open the OpenAlex →

Who are the most-cited researchers behind AgeneBio (United States)?

PICO Portaltop researchers by citations

Richard C. Mohs · Dementia and Cognitive Impairment Research

385 works59,965 citations

What are the most-cited papers on AgeneBio (United States)?

PICO Portalmost cited works

Phase 3 Trials of Solanezumab for Mild-to-Moderate Alzheimer's Disease

Rachelle S. Doody, Ronald G. Thomas, Martin R. Farlow, Takeshi Iwatsubo, Bruno Vellas, Steven Joffe, Karl Kieburtz, Rema Raman, Xiaoying Sun, Paul Aisen, Eric Siemers, Hong Liu‐Seifert, Richard C. Mohs

New England Journal of Medicine. 20141,654 CitationsOPEN ACCESS

Development of Cognitive Instruments for Use in Clinical Trials of Antidementia Drugs

Richard C. Mohs, David S. Knopman, Ronald C. Petersen, Steven H. Ferris, Chris Ernesto, Michael Grundman, Mary Sano, Linas A. Bieliauskas, David Geldmacher, Chris M. Clark, Leon J. Thal

Alzheimer Disease & Associated Disorders. 1997708 Citations

High, usual and impaired functioning in community-dwelling older men and women: Findings from the MacArthur Foundation Research Network on successful aging

Lisa Berkman, Teresa E. Seeman, Marilyn Albert, Dan G. Blazer, Robert L. Kahn, Richard C. Mohs, Caleb E. Finch, Edward L. Schneider, Carl W. Cotman, Gerald E. McClearn, John R. Nesselroade, David L. Featherman, Norman Garmezy, Guy M. McKhann, Gilbert Brim, Denis J. Prager, John W. Rowe

Journal of Clinical Epidemiology. 1993510 CitationsOPEN ACCESS

Development of cognitive instruments for use in clinical trials of antidementia drugs: additions to the Alzheimer's Disease Assessment Scale that broaden its scope. The Alzheimer's Disease Cooperative Study.

Richard C. Mohs, David S. Knopman, R. Petersen, Steven H. Ferris, Christopher Ernesto, Michael Grundman, Mary Sano, Linas A. Bieliauskas, David Geldmacher, Camilla N. Clark, L. J. Thal

PubMed. 1997494 Citations

How much of the research on AgeneBio (United States) is open access?

PICO Portalopen access share

50%OPEN ACCESS

Gold

Green

Hybrid

Bronze

50%

Closed

50%